About
Research
Patient Care
Education
Community
Jun 28, 2024 | The Cancer Letter
Miguel Villalona Calero named deputy director of UCI Chao Family Comprehensive Cancer Center
Miguel Villalona Calero was named deputy director of the University of California, Irvine Chao Family Comprehensive Cancer Center and division chief for hematology/oncology. He will start on July 8.
Jun 27, 2024 | UCI Health
Reimagining cancer care for all of Orange County
When the UCI Health Chao Family Comprehensive Cancer Center's second clinical hub opens its doors July 16, the spacious, state-of-the-art facility in Irvine will extend elite cancer care within reach of residents throughout Orange County and beyond.
UCI CFCCC Bulletin
June 26, 2024
Jun 26, 2024 | UCI School of Physical Sciences
Professor Gregory Weiss Awarded UC Irvine Anti-Cancer Challenge Funding
The Weiss Lab studies the biochemistry of the molecules that make life function, and the new funding will support research into molecules called enzymes that play a key role in the spread of cancer cells in the human body. Weiss plans to work with colleagues in the UC Irvine Chao Family Comprehensive Cancer Center Cancer Control program to create a plan to connect with members of the AAPI community who are willing to be a part of the lab’s research.
Jun 21, 2024 | LAist
Massive AAPI Cancer Study
The first national long-term study about cancer among Asian Americans has been launched to investigate health disparities among ethnic groups and uncover risk factors. “For example, Vietnamese have historically had higher rates of cervical cancer,” said Sora Tanjasiri, a public health professor at UC Irvine. “Koreans have higher rates of liver cancer and stomach cancer. You have to look at the nuances.”
Jun 17, 2024 | UCI Public Health
UC Irvine joins a national network of partners to address cancer, the leading cause of death, among Asian Americans
Asian Americans have become the first racial/ethnic group for whom cancer is the leading cause of death. Yet, Asian Americans are often underrepresented in clinical trials and cancer research. To address this, the NCI has awarded $12.45 million to create a national cohort called ASPIRE.
June 12, 2024
Jun 10, 2024
‘Cutting the cable’ between CD8+ T and T regulatory cells enhances checkpoint immunotherapy
“Our latest research reveals that CD8+ T cells, activated by PD-1 blockade to target melanoma, also interact with T regulatory cells, which subsequently dampen the immune response against the tumor,” said corresponding author Francesco Marangoni, UC Irvine assistant professor of physiology & biophysics.
Jun 04, 2024
UCI Health cancer specialists share research at national forum
UCI Health cancer clinicians and scientists presented key findings and insights that will help advance cancer research and care at the 2024 annual meeting of the American Society of Clinical Oncology (ASCO), one of the world’s largest scientific gatherings in the field.
May 31, 2024
UCI Anti-Cancer Challenge awards $1 million for promising cancer research
The UCI Anti-Cancer Challenge has awarded $1 million raised in 2023 to fund a new round of transformative research projects at the UCI Health Chao Family Comprehensive Cancer Center and its pediatric cancer affiliate, Children’s Hospital of Orange County (CHOC).